Deal to acquire Vascular Solutions finalized by Teleflex | Torax Medical to be acquired by Ethicon | Funding round pulls in $2.6M for ALung Technologies
February 20, 2017
ADVAMED SmartBrief
News for medical technology professionals
Top Story
Deal to acquire Vascular Solutions finalized by Teleflex
The $1 billion acquisition of Vascular Solutions has been completed by Teleflex after receiving approval from Vascular Solutions' shareholders. The $56-per-share transaction expands Teleflex's vascular and interventional businesses with the addition of a portfolio of over 90 coronary and peripheral vascular devices. (Boston) (2/17),  Medical Devices Business Review (U.K.) (2/20) 
LinkedIn Twitter Facebook Google+ Email
Business & Market Trends
Torax Medical to be acquired by Ethicon
Johnson & Johnson subsidiary Ethicon has agreed to pay an undisclosed amount for Minnesota-based Torax Medical, a maker of surgical devices for treating gastroesophageal reflux disease and bowel incontinence. The acquisition is expected to be completed by the end of next month.
The Business Journals (tiered subscription model)/Cincinnati (2/17),  Seeking Alpha (free registration) (2/18) 
LinkedIn Twitter Facebook Google+ Email
Funding round pulls in $2.6M for ALung Technologies
A round of debt and options financing involving 37 unnamed sources has brought in $2.6 million for Pittsburgh-based ALung Technologies, according to a filing with the SEC. The company, which makes the Hemolung RAS extracorporeal carbon dioxide removal device for treating acute respiratory failure, did not disclose how it intends to use the proceeds and is still seeking to raise $1.4 million in the round. (Boston) (2/17) 
LinkedIn Twitter Facebook Google+ Email
Irish medtech company gets $2.2M boost
Financing worth about $2.2 million has been secured by Irish medtech company OncoMark from various investors that include Kernel Capital and the Galway HBAN MedTech syndicate. The money will be used to commercialize the company's OncoMasTR test, which uses screening to lower the number of patients undergoing unnecessary chemotherapy for breast cancer, as well as to expand its workforce.
The Journal (Dublin, Ireland) (2/18) 
LinkedIn Twitter Facebook Google+ Email
Report predicts growth for US intraoperative neuromonitoring market
A report from Orbis Research predicts the US intraoperative neuromonitoring market will see a 9% compound annual growth rate through 2020 due to a higher demand for patient safety. Among the key market players are Medtronic, NuVasive, Biotronic NeuroNetwork, Computational Diagnostics and Natus Medical. (2/17) 
LinkedIn Twitter Facebook Google+ Email
Science & Health
Data show positive results for Insulet's hybrid closed-loop system
Data from a 24-patient feasibility study of Insulet's Omnipod Horizon hybrid closed-loop system showed positive results in patients with type 1 diabetes. At 36 hours, use of a modified version of the Omnipod, along with Insulet's personalized model predictive control algorithm and a Dexcom continuous glucose monitor, demonstrated safety, significantly improved overnight glucose control and lowered hypoglycemia during the day and night.
Drug Delivery Business News (2/17) 
LinkedIn Twitter Facebook Google+ Email
Hot Topics
Government & Regulatory
Medtronic's leadless pacemaker secures approval from Japan
Japan's Pharmaceuticals and Medical Device Agency has given Medtronic approval for its Micra transcatheter pacing system, a leadless pacemaker intended to be implanted in the right ventricle using a catheter to provide single-chamber pacing. The device can be used for full-body MRI scans and has an estimated battery life of 12 years.
FDAnews (2/20), (Boston) (2/17) 
LinkedIn Twitter Facebook Google+ Email
Hologic gets premarket approval from FDA for HCV assay
The FDA has given Hologic premarket approval for its Aptima HCV Quant Dx assay, which is intended for viral load measurement and confirmation of hepatitis C virus infection. The assay, which operates on the automated Panther system, quantifies sustained antiviral response throughout all major genotypes and uses real-time transcription-mediated amplification.
FDAnews (2/17) 
LinkedIn Twitter Facebook Google+ Email
Recall of Zimmer Biomet's shoulder replacement device labeled Class I by FDA
A recall initiated by Zimmer Biomet involving 3,662 units of its Comprehensive Reverse Shoulder System has been classified by the FDA as Class I. The recall was issued because the shoulder replacement devices demonstrate a higher rate of fractures, which may necessitate revision surgeries, compared with what is indicated on the label. (Boston) (2/17) 
LinkedIn Twitter Facebook Google+ Email
AdvaMed Events and Education
2017 Latin America Compliance Conference
Feb. 21-22, 2017 | Bogota, Colombia
Developed by industry and association leaders for the medical device industry and based on the latest and emerging trends in global medical technology compliance, the 2017 Latin America Compliance Conference is the most comprehensive medical technology meeting for device industry executives, specialty device industry lawyers, compliance professionals, international policymakers and other industry stakeholders focused on Latin American compliance issues. The conference will bring together device industry regulators, compliance professionals, legal counsel, senior executives and industry observers to analyze the major compliance challenges of the day and to discuss approaches to practical and effective management and compliance across the region. Learn more.
LinkedIn Twitter Facebook Google+ Email
Start saving with the AdvaMed Purchasing Group
The AdvaMed Purchasing Group is a new member-only benefit that helps companies purchase the very best goods and services from nationally recognized suppliers at the very best cost, using a trusted and proven vetting system and the collective purchasing power of our membership. Participation is free for AdvaMed members, and there are no minimum commitments. Get started today.
LinkedIn Twitter Facebook Google+ Email
Learn more about AdvaMed:
About AdvaMed | Join | Courses | Events | Newsroom
powered by
Director of Quality Assurance & Regulatory Affairs
Medical Device Senior Consultant
This Mouse must give up one of his Mouse ways of seeing things in order that he may grow.
Hyemeyohsts Storm,
LinkedIn Twitter Facebook Google+ Email
Sign Up
SmartBrief offers 200+ newsletters
Learn more about the SmartBrief audience
Subscriber Tools:
Contact Us:
Advertising  -  Meryl Harold
P: 202.407.7828
Jobs Contact  -
Editor  -  Lisa Gough
Mailing Address:
SmartBrief, Inc.®, 555 11th ST NW, Suite 600, Washington, DC 20004
© 1999-2017 SmartBrief, Inc.®
Privacy policy |  Legal Information